SCHEMBL4851040

SCHEMBL4851040

CC(C)(C)NNC(=O)c1sccc1NCc1ccnc2ccccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.61
RAF1 P04049 1/20 0.61
LCK P06239 1/20 0.61
RET P07949 1/20 0.61
CYP3A4 P08684 1/20 0.61
KIT P10721 1/20 0.61
MAP3K20 Q9NYL2 1/20 0.61
RIPK3 Q9Y572 1/20 0.61
MAPK9 P45984 4/20 0.45
MAPK8 P45983 4/20 0.45
MAPK10 P53779 4/20 0.45
FLT1 P17948 5/20 0.42
HDAC6 Q9UBN7 2/20 0.40
ATG4B Q9Y4P1 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4847094 0.84 KDR (0.65) KDRRAF1LCKRETCYP3A4
SCHEMBL4848887 0.84 KDR (0.62) KDRRAF1LCKRETCYP3A4
SCHEMBL3731983 0.82 KDR (0.61) KDRRAF1LCKRETCYP3A4
SCHEMBL3733006 0.81 MAPK10 (0.65) KDRRAF1LCKRETCYP3A4
SCHEMBL4844255 0.81 KDR (0.66) KDRRAF1LCKRETCYP3A4
Hydrochloric Acid SCHEMBL3737793 0.81 KDR (0.60) KDRRAF1LCKRETCYP3A4
SCHEMBL4276210 0.81 KDR (0.60) KDRRAF1LCKRETCYP3A4
SCHEMBL4843595 0.81 KDR (0.63) KDRRAF1LCKRETCYP3A4
SCHEMBL4852414 0.81 KDR (0.61) KDRRAF1LCKRETCYP3A4
SCHEMBL4851882 0.81 KDR (0.61) KDRRAF1LCKRETCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7388012-B2 (Hydrazido)(amino)thiophene compounds OSI PHARMACEUTICALS, INC. (US) 2008-06-17 US claimed
US-20060063773-A1 (Hydrazido)(amino)thiophene compounds OSI PHARMACEUTICALS, INC. 2006-03-23 US claimed
US-7388012-B2 (Hydrazido)(amino)thiophene compounds OSI PHARMACEUTICALS, INC. (US) 2008-06-17 US disclosed
US-7388012-B2 (Hydrazido)(amino)thiophene compounds OSI PHARMACEUTICALS, INC. (US) 2008-06-17 US disclosed
US-7388012-B2 (Hydrazido)(amino)thiophene compounds OSI PHARMACEUTICALS, INC. (US) 2008-06-17 US disclosed
US-20060063773-A1 (Hydrazido)(amino)thiophene compounds OSI PHARMACEUTICALS, INC. 2006-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063773-A1 (Hydrazido)(amino)thiophene compounds KIT, BRDT, BRCA1 KDR 1955/4885RAF1 929/4885LCK 453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.